Q: A general question.
What happens if shareholders don't vote in the annual meeting's voting ballot that we receive from companies in our mail?
Mostly it's about board elections, approving executive pays, approving the auditing company and a few other shareholder proposals that we are not fully aware of and it consumes quiet a bit of our time on voting as sometimes there are 15 or more questions.
If we don't submit our vote is it considered as voted as per management recommendations or management gets to vote on our behalf or its considered abstain ?
Q: Pfizer Inc is planning to raise $31 billion through its largest debt offering to finance its proposed acquisition of Seagen Inc, the drugmaker said late on Tuesday.
Q: HI 5i ,
I ama DYI retired investor, looking to add a few covered call ETF's to my TFSA, do you have a favorite what are your thoughts in this realm for added dividend income?
Thanks P
Q: Hi 5i,
what Brookfield entity has the largest exposure to Oaktree?
Is it BAM or BN or something else?
With credit markets tightening would you consider Mr. Marks skills as an incredible advantage for Brookfield?
thanks
Q: I would like to increase my health care sector and am considering adding to ABBV or start a new position in PFE. The valuation of PFE looks good in comparison. For a long term hold in a LIF, which one would you select? Thanks
Gary
I’m thinking of selling a few stocks at a loss to balance out capital gains (I trimmed NVDA since my stock position got too high). I can cover an equivalent loss by selling two (or a combination of all 3) of the following stocks: DIS, TTD and CRWD. I bought all 3 at a much higher price. CRWD and TTD have had a nice bounce and I’m thinking that the near term environment of debt ceiling and sell in May could be a good time to take losses. I’m wondering if you have other items I should consider related to selling now versus later this year? If later, what would be a good time to consider?
I have other similar tech stocks such as GOOG and ZS and I’m wondering if I should consider another proxy for any or not bother? And I’m also wondering about re-buying at a reasonable entry point after 30 days for any of the 3 or simply move on?
Q: Why is this preferred share index trading at 52 wk lows ? I believe interest rates are nearing their peak and when the numbers begin to show the recession spreading though out the economy ( rising unemployment etc.), feds may begin to ease.
Q: How would you rank these companies in terms of overall growth going forward in the energy sector. I'm currently holding TOU, WCP, TVE and KEL.
Largest position is in TOU at around 3% (+44%) and smaller positions in WCP (+69%), TVE (-9%) and KEL (-14%) . I could add to any of these names. How does TOU compare vs AR in terms of natural gas companies? AR has pulled back in the last year and today it was up close to 9% which I couldn't find any news. I'm thinking of selling some TOU or just starting a new position in AR. I also like that AR is buying back shares, have strong insider ownership, founder operated, strong margins and balance sheet. All metrics seem pretty strong with AR, any red flags that you see? Thoughts?
Q: I have always been puzzled by cyclical stocks. By way of example, I hold NTR in a non-registered account and have ridden it up (by 50%) and now down to 15%. Is the strategy for dealing with these stocks simply to ride out the bad times, knowing they will eventually cycle back? Or should I be selling on the way down and trying to figure out the best entry point when the stock starts to rebound? The matter is complicated, of course, by the tax consequences of selling in a non-registered account. Your advice regarding buying and selling cyclical stocks would be most appreciated. Thank you.
Q: Reportedly ENB is having trouble with its line with a Native Indian band in US. Is all the Dividend subject to Div.Tax credit? Is this a good entry point or U prefer another stock?Buy in non-registered account,Tfsa or RIF? Txs for U usual great advice & views
Q: I just wonder about the analyst upgrades and downgrades reported by the Globe&Mail today on NTR. Here is the exact quote:
* Berenberg’s Aron Ceccarelli downgraded Nutrien Ltd. (NTR-N, NTR-T -1.84%decrease) to “hold” from “buy” and dropped his target to US$49 from US$92. The average target on the Street is US$85.59.
If the downgrade is so substantial (U.S. $49 vs. average of U.S. $85.59) don't they required some additional explanation? These "experts" should know many investors would take the numbers at face value and perhaps make some eventually regrettable decisions. Maybe the Globe just can't include all the details in such a short blurb, but if the numbers are so material should either the analyst, or the Globe, provide more details?
What's your view on this? And would you by any chance have those missing details? Thanks.
Q: Hi Peter/Ryan, I've been holding EGLX in my RRSP account since you added it to your portfolio. My average cost is 3.92 for 2000 shares so what could be a good strategy for shareholders. Would you hold and wait for the recovery or sell and buy it back after the month. Is there any one strategy better than the other, hoping of course and thinking there is a future for the company and you wanted to hold it for the long term. Thanks